{"id":114794,"date":"2021-01-20T17:07:11","date_gmt":"2021-01-20T20:07:11","guid":{"rendered":"https:\/\/www.suno.com.br\/noticias\/?p=114794"},"modified":"2021-02-17T22:03:03","modified_gmt":"2021-02-18T01:03:03","slug":"hypera-hype3-cade-aprova-compra-takeda","status":"publish","type":"post","link":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/","title":{"rendered":"Hypera (HYPE3): Cade aprova compra de portf\u00f3lio de medicamentos da Takeda"},"content":{"rendered":"<p>O <a href=\"https:\/\/www.suno.com.br\/artigos\/cade\/\">Conselho Administrativo de Defesa Econ\u00f4mica (Cade)<\/a> anunciou nesta quarta-feira (20) a aprova\u00e7\u00e3o da aquisi\u00e7\u00e3o do portf\u00f3lio de 18 medicamentos sem prescri\u00e7\u00e3o da Takeda Pharmaceuticals Internacional pela <a href=\"https:\/\/www.suno.com.br\/acoes\/hype3\/\"><strong>Hypera Pharma<\/strong> (HYPE3)<\/a>. A prova\u00e7\u00e3o teve restri\u00e7\u00f5es.<\/p>\t<div class=\"wrapper-featured-image\">\n\t\t<figure class=\"spotlightImg\">\n\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 768px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/fdb15091-hypera-400x200.webp\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" class=\"newsContent__article__imgCapa lazyloadDisabled \" src=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/fdb15091-hypera-800x450.webp\" width=\"800\" height=\"450\" alt=\"Hypera (HYPE3): Cade aprova compra de portf\u00f3lio de medicamentos da Takeda\" fetchpriority=high \/>\n\t\t\t<\/picture>\n\n\t\t\t<figcaption class=\"wp-caption-text wp-caption-text--show\">Resultados da HYPE3 no 3T25 mostram margens fortes e caixa recorde, segundo BTG e BB Investimentos.<\/figcaption>\n\t\t<\/figure>\n\t<\/div>\n\n\n\t<p>\n\t\t<a href=\"https:\/\/lp.suno.com.br\/planilha-controle-gastos\/\" target=\"_blank\" data-element=\"shortcode-suno-banner\" title=\"Banner SUNO, clique e saiba mais\">\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 500px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/400x300-Planilha-controle-de-gastos.png\">\n\t\t\t\t<img class=\"newsContent__article__imgCapa newsContent__article__imgCapa--banner\"\n\t\t\t\t\tsrc=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/1420x240-Planilha-controle-de-gastos.png\"\n\t\t\t\t\tdata-promo-id=\"101751\"\t\t\t\t\t\t\t\t\t\twidth='1420' height='240'\t\t\t\t\talt=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/1420x240-Planilha-controle-de-gastos.png\"\n\t\t\t\t>\n\t\t\t<\/picture>\n\t\t<\/a>\n\t<\/p>\n\n\n<p>Assim, dentre as linhas de produtos que a Hypera passa a deter est\u00e3o:<\/p>\n<ul>\n<li>Dramin;<\/li>\n<li>Nebacetin;<\/li>\n<li>Neosaldina;<\/li>\n<li>Eparema.<\/li>\n<\/ul>\n<p>A parte comprada da Takeda pela farmac\u00eautica brasileira teve receita l\u00edquida de aproximadamente R$ 900 milh\u00f5es em 2019.<\/p>\n<p><a href=\"https:\/\/lp.suno.com.br\/suno-one\/\">Suno One: acesse gratuitamente eBooks, Minicursos, Artigos e Video Aulas sobre investimentos com um \u00fanico cadastro. Clique para saber mais!<\/a><\/p>\n<p>O portf\u00f3lio adquirido pela brasileira possui produtos das \u00e1reas de:<\/p>\n<ul>\n<li>cardiologia<\/li>\n<li>diabetes<\/li>\n<li>endocrinologia<\/li>\n<li>gastroenterologia<\/li>\n<li>sistema respirat\u00f3rio<\/li>\n<li>cl\u00ednica geral<\/li>\n<\/ul>\n<blockquote class=\"twitter-tweet\">\n<p dir=\"ltr\" lang=\"pt\">Resultado: Tribunal aprova, com restri\u00e7\u00f5es, compra de portf\u00f3lio de medicamentos da Takeda pela Hypera. (Ato de concentra\u00e7\u00e3o n\u00ba 3553\/2020-91)<\/p>\n<p>\u2014 Conselho Administrativo de Defesa Econ\u00f4mica (@CadeGovBr) <a href=\"https:\/\/twitter.com\/CadeGovBr\/status\/1351948824785391616?ref_src=twsrc%5Etfw\">January 20, 2021<\/a><\/p><\/blockquote>\n<p><script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script><br \/>\nEm rela\u00e7\u00e3o a restri\u00e7\u00e3o, o <strong>Cade<\/strong> explicou que as empresas se comprometeram a vender os produtos <strong>Xantinon<\/strong> e Xantinon Complex, para eliminar preocupa\u00e7\u00f5es relacionadas a concorr\u00eancia no mercado de medicamentos hepatioprotetores e lipotr\u00f3picos.<\/p>\n<p>Vale lembrar que a venda dos produtos j\u00e1 aconteceu, quando a Hypera os vendeu para a<strong> Uni\u00e3o Qu\u00edmica Farmac\u00eautica Nacional<\/strong> em meados de outubro do ano passado. O Cade tamb\u00e9m aprovou a opera\u00e7\u00e3o.<\/p>\n<h2>Hypera compra portf\u00f3lio de medicamentos da Takeda<\/h2>\n<p>Em mar\u00e7o de 2020 a Hypera confirmou que adquiriu o portf\u00f3lio de medicamentos sem prescri\u00e7\u00e3o da <strong>Takeda<\/strong> por US$ 825 milh\u00f5es (cerca de R$ 3,7 bilh\u00f5es).<\/p>\n\t<p>\n\t\t<a href=\"https:\/\/lp.suno.com.br\/ebook-como-analisar-uma-acao\/\" target=\"_blank\" data-element=\"shortcode-suno-banner\" title=\"Banner SUNO, clique e saiba mais\">\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 500px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/Ebook-Acoes-Mobile.jpg\">\n\t\t\t\t<img class=\"newsContent__article__imgCapa newsContent__article__imgCapa--banner\"\n\t\t\t\t\tsrc=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/Ebook-Acoes-Desktop.jpg\"\n\t\t\t\t\tdata-promo-id=\"378302\"\t\t\t\t\t\t\t\t\t\twidth='1420' height='286'\t\t\t\t\talt=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/Ebook-Acoes-Desktop.jpg\"\n\t\t\t\t>\n\t\t\t<\/picture>\n\t\t<\/a>\n\t<\/p>\n\n\n<p>A Hypera informou que j\u00e1 havia tratado com os bancos sobre as <a href=\"https:\/\/www.suno.com.br\/artigos\/concessao-de-credito\/\">linhas de cr\u00e9dito<\/a> que seriam necess\u00e1rias para o financiamento da negocia\u00e7\u00e3o com a Takeda. A maior <strong>ind\u00fastria farmac\u00eautica<\/strong> do Brasil utilizou R$ 3,5 bilh\u00f5es para financiar a compra.<\/p>\n<p>&#8220;A Hypera Pharma e a Takeda tamb\u00e9m assinar\u00e3o acordo de fabrica\u00e7\u00e3o e fornecimento em conex\u00e3o com a transa\u00e7\u00e3o, por meio do qual a Takeda continuar\u00e1 a fornecer produtos \u00e0 companhia&#8221;, comunicou a farmac\u00eautica brasileira.<\/p>\n\t<div data-element=\"shortcode-read-more\" class=\"knowMore\">\n\t\t\t\t<span class=\"knowMore__title\">Veja tamb\u00e9m<\/span>\n\t\t\t\t<a class=\"knowMore__link\" href=\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-lucro-2t20\/\">\n\t\t\tHypera Pharma (HYPE3) registra lucro de R$ 345,6 mi no 3T20; alta de 29,4%\t\t<\/a>\n\t<\/div>\n\n\n<p>Vale destacar que a Hypera Pharma j\u00e1 \u00e9 dona da <strong>Neo Qu\u00edmica<\/strong> e da <strong>Montecorp,<\/strong> al\u00e9m de outros laborat\u00f3rios brasileiros.<\/p>\n<h2>\u00daltima cota\u00e7\u00e3o da HYPE3<\/h2>\n<p>Por volta das 16h45 de hoje, a a\u00e7\u00e3o da <strong>Hypera (HYPE3)<\/strong> operava em queda de 1,30%, valendo R$ 34,95.<\/p>\n\t<p>\n\t\t<a href=\"https:\/\/lp.suno.com.br\/planilha-de-controle-de-investimentos\/\" target=\"_blank\" data-element=\"shortcode-suno-banner\" title=\"Banner SUNO, clique e saiba mais\">\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 500px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/400x300-Controle-de-Investimentos.png\">\n\t\t\t\t<img class=\"newsContent__article__imgCapa newsContent__article__imgCapa--banner\"\n\t\t\t\t\tsrc=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/1420x240-Controle-de-Investimentos.png\"\n\t\t\t\t\tdata-promo-id=\"75934\"\t\t\t\t\t\t\t\t\t\twidth='1420' height='240'\t\t\t\t\talt=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/1420x240-Controle-de-Investimentos.png\"\n\t\t\t\t>\n\t\t\t<\/picture>\n\t\t<\/a>\n\t<\/p>\n\n\n","protected":false},"excerpt":{"rendered":"<p>O Conselho Administrativo de Defesa Econ\u00f4mica (Cade) anunciou nesta quarta-feira (20) a aprova\u00e7\u00e3o da aquisi\u00e7\u00e3o do portf\u00f3lio de 18 medicamentos sem prescri\u00e7\u00e3o da Takeda Pharmaceuticals Internacional pela Hypera Pharma (HYPE3). A prova\u00e7\u00e3o teve restri\u00e7\u00f5es. Resultados da HYPE3 no 3T25 mostram margens fortes e caixa recorde, segundo BTG e BB Investimentos. Assim, dentre as linhas de [&hellip;]<\/p>\n","protected":false},"author":39,"featured_media":114799,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[64],"tags":[501],"suno_strategy":[],"class_list":["post-114794","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-negocios","tag-hypera-pharma-hype3"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Hypera: Cade aprova compra de portf\u00f3lio de medicamentos da Takeda<\/title>\n<meta name=\"description\" content=\"O Cade aprovou, com restri\u00e7\u00e3o, a aquisi\u00e7\u00e3o de portf\u00f3lio medicamentos da Takeda pela Hypera Pharma (HYPE3). Clique aqui e saiba mais.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hypera: Cade aprova compra de portf\u00f3lio de medicamentos da Takeda\" \/>\n<meta property=\"og:description\" content=\"O Cade aprovou, com restri\u00e7\u00e3o, a aquisi\u00e7\u00e3o de portf\u00f3lio medicamentos da Takeda pela Hypera Pharma (HYPE3). Clique aqui e saiba mais.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/\" \/>\n<meta property=\"og:site_name\" content=\"Suno Not\u00edcias\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/sunoresearch\" \/>\n<meta property=\"og:image\" content=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/fdb15091-hypera.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Laura Moutinho\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@sunoresearch\" \/>\n<meta name=\"twitter:site\" content=\"@sunoresearch\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Laura Moutinho\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/\"},\"author\":{\"name\":\"Laura Moutinho\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/3df0d2808748b74496efe5dbeaef2c72\"},\"headline\":\"Hypera (HYPE3): Cade aprova compra de portf\u00f3lio de medicamentos da Takeda\",\"datePublished\":\"2021-01-20T20:07:11+00:00\",\"dateModified\":\"2021-02-18T01:03:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/\"},\"wordCount\":429,\"publisher\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/fdb15091-hypera-jpg.webp\",\"keywords\":[\"Hypera Pharma (HYPE3)\"],\"articleSection\":[\"Neg\u00f3cios\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/\",\"name\":\"Hypera: Cade aprova compra de portf\u00f3lio de medicamentos da Takeda\",\"isPartOf\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/fdb15091-hypera-jpg.webp\",\"datePublished\":\"2021-01-20T20:07:11+00:00\",\"dateModified\":\"2021-02-18T01:03:03+00:00\",\"description\":\"O Cade aprovou, com restri\u00e7\u00e3o, a aquisi\u00e7\u00e3o de portf\u00f3lio medicamentos da Takeda pela Hypera Pharma (HYPE3). Clique aqui e saiba mais.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/#primaryimage\",\"url\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/fdb15091-hypera-jpg.webp\",\"contentUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/fdb15091-hypera-jpg.webp\",\"width\":1000,\"height\":800,\"caption\":\"Resultados da HYPE3 no 3T25 mostram margens fortes e caixa recorde, segundo BTG e BB Investimentos.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Not\u00edcias\",\"item\":\"https:\/\/www.suno.com.br\/noticias\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neg\u00f3cios\",\"item\":\"https:\/\/www.suno.com.br\/noticias\/negocios\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Hypera (HYPE3): Cade aprova compra de portf\u00f3lio de medicamentos da Takeda\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#website\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/\",\"name\":\"Suno Not\u00edcias\",\"description\":\"Seu portal de informa\u00e7\u00e3o sobre o mundo dos investimentos\",\"publisher\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.suno.com.br\/noticias\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#organization\",\"name\":\"Suno Not\u00edcias\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png\",\"contentUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png\",\"width\":180,\"height\":180,\"caption\":\"Suno Not\u00edcias\"},\"image\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/facebook.com\/sunoresearch\",\"https:\/\/x.com\/sunoresearch\",\"https:\/\/www.instagram.com\/suno\",\"https:\/\/www.linkedin.com\/company\/suno-research\/\",\"https:\/\/www.youtube.com\/c\/sunoresearch\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/3df0d2808748b74496efe5dbeaef2c72\",\"name\":\"Laura Moutinho\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7571c7c8ca3a6fca5e41384ece5557ff?s=96&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7571c7c8ca3a6fca5e41384ece5557ff?s=96&r=g\",\"caption\":\"Laura Moutinho\"},\"description\":\"Estagi\u00e1ria na Suno Not\u00edcias, escreve not\u00edcias que afetam o mercado financeiro. Estuda administra\u00e7\u00e3o na Universidade Presbiteriana Mackenzie.\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/author\/laura-moutinho\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hypera: Cade aprova compra de portf\u00f3lio de medicamentos da Takeda","description":"O Cade aprovou, com restri\u00e7\u00e3o, a aquisi\u00e7\u00e3o de portf\u00f3lio medicamentos da Takeda pela Hypera Pharma (HYPE3). Clique aqui e saiba mais.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/","og_locale":"pt_BR","og_type":"article","og_title":"Hypera: Cade aprova compra de portf\u00f3lio de medicamentos da Takeda","og_description":"O Cade aprovou, com restri\u00e7\u00e3o, a aquisi\u00e7\u00e3o de portf\u00f3lio medicamentos da Takeda pela Hypera Pharma (HYPE3). Clique aqui e saiba mais.","og_url":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/","og_site_name":"Suno Not\u00edcias","article_publisher":"https:\/\/facebook.com\/sunoresearch","og_image":[{"width":1000,"height":800,"url":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/fdb15091-hypera.jpg","type":"image\/jpeg"}],"author":"Laura Moutinho","twitter_card":"summary_large_image","twitter_creator":"@sunoresearch","twitter_site":"@sunoresearch","twitter_misc":{"Escrito por":"Laura Moutinho","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/#article","isPartOf":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/"},"author":{"name":"Laura Moutinho","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/3df0d2808748b74496efe5dbeaef2c72"},"headline":"Hypera (HYPE3): Cade aprova compra de portf\u00f3lio de medicamentos da Takeda","datePublished":"2021-01-20T20:07:11+00:00","dateModified":"2021-02-18T01:03:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/"},"wordCount":429,"publisher":{"@id":"https:\/\/www.suno.com.br\/noticias\/#organization"},"image":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/#primaryimage"},"thumbnailUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/fdb15091-hypera-jpg.webp","keywords":["Hypera Pharma (HYPE3)"],"articleSection":["Neg\u00f3cios"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/","url":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/","name":"Hypera: Cade aprova compra de portf\u00f3lio de medicamentos da Takeda","isPartOf":{"@id":"https:\/\/www.suno.com.br\/noticias\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/#primaryimage"},"image":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/#primaryimage"},"thumbnailUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/fdb15091-hypera-jpg.webp","datePublished":"2021-01-20T20:07:11+00:00","dateModified":"2021-02-18T01:03:03+00:00","description":"O Cade aprovou, com restri\u00e7\u00e3o, a aquisi\u00e7\u00e3o de portf\u00f3lio medicamentos da Takeda pela Hypera Pharma (HYPE3). Clique aqui e saiba mais.","breadcrumb":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/#primaryimage","url":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/fdb15091-hypera-jpg.webp","contentUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/fdb15091-hypera-jpg.webp","width":1000,"height":800,"caption":"Resultados da HYPE3 no 3T25 mostram margens fortes e caixa recorde, segundo BTG e BB Investimentos."},{"@type":"BreadcrumbList","@id":"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Not\u00edcias","item":"https:\/\/www.suno.com.br\/noticias\/"},{"@type":"ListItem","position":2,"name":"Neg\u00f3cios","item":"https:\/\/www.suno.com.br\/noticias\/negocios\/"},{"@type":"ListItem","position":3,"name":"Hypera (HYPE3): Cade aprova compra de portf\u00f3lio de medicamentos da Takeda"}]},{"@type":"WebSite","@id":"https:\/\/www.suno.com.br\/noticias\/#website","url":"https:\/\/www.suno.com.br\/noticias\/","name":"Suno Not\u00edcias","description":"Seu portal de informa\u00e7\u00e3o sobre o mundo dos investimentos","publisher":{"@id":"https:\/\/www.suno.com.br\/noticias\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.suno.com.br\/noticias\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/www.suno.com.br\/noticias\/#organization","name":"Suno Not\u00edcias","url":"https:\/\/www.suno.com.br\/noticias\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/","url":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png","contentUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png","width":180,"height":180,"caption":"Suno Not\u00edcias"},"image":{"@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/sunoresearch","https:\/\/x.com\/sunoresearch","https:\/\/www.instagram.com\/suno","https:\/\/www.linkedin.com\/company\/suno-research\/","https:\/\/www.youtube.com\/c\/sunoresearch"]},{"@type":"Person","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/3df0d2808748b74496efe5dbeaef2c72","name":"Laura Moutinho","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7571c7c8ca3a6fca5e41384ece5557ff?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7571c7c8ca3a6fca5e41384ece5557ff?s=96&r=g","caption":"Laura Moutinho"},"description":"Estagi\u00e1ria na Suno Not\u00edcias, escreve not\u00edcias que afetam o mercado financeiro. Estuda administra\u00e7\u00e3o na Universidade Presbiteriana Mackenzie.","url":"https:\/\/www.suno.com.br\/noticias\/author\/laura-moutinho\/"}]}},"default_loop_html":"<div class=\"cardsPage__listCard__boxs\"><div class=\"cardsPage__listCard__boxs__img\"><a href=\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/\"><img class=\"mask\" src=\"https:\/\/www.suno.com.br\/noticias\/wp-content\/themes\/suno\/resources\/images\/spotlight\/spotlight1img\/bg-mask.png\" alt=\"Image Mask\"\/><img src=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/fdb15091-hypera-400x200.webp\" alt=\"Hypera (HYPE3): Cade aprova compra de portf\u00f3lio de medicamentos da Takeda\"\/><\/a><span class=\"spotlightCategory\"><a href=\"https:\/\/www.suno.com.br\/noticias\/negocios\/\">Neg\u00f3cios<\/a><\/span><\/div><div class=\"cardsPage__listCard__boxs__content\"><a href=\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-cade-aprova-compra-takeda\/\"><h2 class=\"content__title\">Hypera (HYPE3): Cade aprova compra de portf\u00f3lio de medicamentos da Takeda<\/h2><\/a><div class=\"newsContent__article__meta\"><div class=\"newsContent__article__meta__authorBox\"><a href=\"https:\/\/www.suno.com.br\/noticias\/author\/laura-moutinho\/\" class=\"authorBox__avatar noMobi\"><img src=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2020\/08\/531ff69d-whatsapp-image-2020-08-03-at-14.54.38-150x150.webp\" alt=\"Laura Moutinho\"><\/a><div class=\"authorBox__name\"><span>por\n\t\t\t<a href=\"https:\/\/www.suno.com.br\/noticias\/author\/laura-moutinho\/\"><span itemprop=\"author\">Laura Moutinho<\/span><\/a><\/span><time datetime=\"2021-01-20T17:07:11-03:00\" itemprop=\"datePublished\">20\/01\/2021 17:07<\/time><\/div><\/div><\/div><\/div><\/div>","single_layout":"posts","amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts\/114794"}],"collection":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/comments?post=114794"}],"version-history":[{"count":0,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts\/114794\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/media\/114799"}],"wp:attachment":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/media?parent=114794"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/categories?post=114794"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/tags?post=114794"},{"taxonomy":"suno_strategy","embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/suno_strategy?post=114794"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}